Drug news
NICE recommends Exogen (Bioventus) for treatment of long bone fractures
NICE has issued guidance on the use of Exogen, an ultrasound bone healing system from Smith & Nephew/Bioventus LLC, that benefits patients and the NHS when used for treating long bone fractures (bone fractures that have failed to heal after nine months). But NICE added that the case for adopting the device routinely for long bone fractures with delayed healing ,those that have not healed after three months, was not accepted because of uncertainties in the evidence.